Abocor SRL
Abocor reported total assets of 10,389 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026).
The score of Abocor shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -95 % Total assets -80 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Abocor's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
Abocor's financial analysis
- Solvency16.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Abocor
Abocor's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0775.821.440
- VAT number
- BE0775821440
- Peppol
- Registered · 0208:0775821440 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Oct 2021
- Registered office
- 4020 Liège
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Abocor (SRL) has been based in Liège since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 17,009 € and equity of 1,718 €; its revenue is not published. Its solvency stands at 16.5%, below the median of its sector (41.5%).
Companies similar to Abocor
Companies in the same business, of comparable size and area, outside its group.
- API Pharma Retail sale of pharmaceutical products Liège · balance sheet 116,460 €
- Belem Consulting Business and other management consultancy activities Liège · balance sheet 45,666 €
- Antha Consult Retail sale of pharmaceutical products Liège · balance sheet 272,102 €
- Novafontis Business and other management consultancy activities Liège · balance sheet 131,719 €
- NE Consult Retail sale of pharmaceutical products Rixensart · balance sheet 15,960 €
- Apharga Retail sale of pharmaceutical products Ferrières · balance sheet 23,536 €
- Formapharma Retail sale of pharmaceutical products Andenne · balance sheet 17,739 €
- Farmacyze Retail sale of pharmaceutical products Ostend · balance sheet 73,863 €
Frequently asked questions about Abocor
What is the revenue of Abocor?
Abocor files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Abocor?
In Belgium, the VAT number is the company number prefixed with BE: BE0775821440 for Abocor, if the company is VAT-registered. Its company number (CBE) is 0775.821.440.
Where is the registered office of Abocor?
According to the CBE register, the registered office of Abocor is in 4020 Liège.
What is the equity of Abocor?
At the close of the 2025 financial year, the equity of Abocor amounts to 1,718 €, a solvency of 16.5% of total assets.
Who manages Abocor?
The register lists 1 active mandates at Abocor. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Abocor
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →